This fusion tyrosine kinase can phosphorylate STAT5 directly and also lead to the activation of JAK2 in both CML and some forms of acute lymphoid leukemia (ALL) [188,189,190,191]. The gene discussed is STAT5B; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.